Reminder: This page provides global information for HCP or scientific research audience that may not be applicable in your country.
Locally approved resources can be found here.
This year, we highlighted our Competitive Advantage at the beginning of the report. We also featured timely topics such as enhancing our drug discovery capabilities through the implementation of AI and visualizing the social impacts of our non-financial activities. You can also find many passionate messages and interviews with our Top Management, outside Directors, and employees.
Click on the link below to learn more about Astellas and its exciting future.
https://www.astellas.com/en/about/astellas-integrated-report
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
The Integrated Report 2026 focuses on Corporate Strategic Plan 2026 (CSP2026), our five-year strategic plan for sustainable growth. Through messages from the President & CEO and other members of Top Management, as well as a dialogue with outside Directors, the report highlights Astellas’ ambitions, priorities and initiatives to create and deliver greater VALUE faster for patients through its patient-centric operating model.
The report also features special articles on next-generation cell and gene therapies and the visualization of Astellas’ corporate value, providing further insights into innovation, social impact and long-term value creation.
Click on the link below to learn more about Astellas and its exciting future.
Integrated Report 2026
